Patent · US Active

sRAGE mimetibody, compositions, methods and uses

US8043616B2 · kind B2 · utility

13Cited by

18References

5Claims

0Family size

Assignee

Centocor, Inc. · US

Inventors

Glenn Mark Anderson · San Ramon, US
Robert Jordan · Walnut Creek, US
Kristen Picha · Malvern, US

Key dates

Filing date	Jul 17, 2008
Grant date	Oct 25, 2011
Priority date	—
Expiry date	May 8, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Mammalian sRAGE mimetibody polypeptides and nucleic acids are disclosed. Methods of utilizing the polypeptides to reduce or inhibit the binding of RAGE and its ligands and to treat RAGE-related diseases are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.